Clinical trial Recruiting at 1 site Interventional Ages 40 to 75

Unilateral vs. Bilateral Resistance Training for Hypertension

Official title: Comparison of the Effects of Unilateral and Bilateral Resistance Training on Heart Rate Variability, Muscle Strength, and Functional Capacity in Individuals With Hypertension: A Randomized Controlled Trial

Run by Hacettepe University · NCT07751445 · Data updated 2026-11-12

This study tests whether exercising with one limb at a time or with both limbs at once can improve heart rate variability, strength, and daily function in adults with hypertension.

Quick facts

Study typeInterventional
Ages40 Years to 75 Years
SexAll
Enrollment54 (estimated)
SponsorHacettepe University
Academic / other
Locations1 site (Tunceli)
StatusRecruiting
StartedJune 22, 2026
Main results expectedSeptember 25, 2026
Study endsOctober 1, 2026
Registry record updatedAugust 7, 2026
Trial IDNCT07751445 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 40–75 years with physician-confirmed hypertension who can safely participate in supervised resistance training.

Probably not a fit

Individuals with other cardiovascular diseases, neurological or psychiatric conditions, orthopedic limitations, or cognitive impairments may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares unilateral and bilateral resistance training against a non-exercise control in adults aged 40–75 with hypertension. Participants are randomly assigned to one of three groups to assess differences in heart rate variability, muscle strength, and functional capacity. The study uses supervised training sessions to ensure safety and consistent progression, with outcomes focused on autonomic function, physical fitness, and daily activity performance. Hypertension-related autonomic dysfunction and reduced muscle strength motivate the investigation of whether the scope of resistance training mass affects cardiovascular and functional adaptations.

Why it matters

Potential benefit: If successful, the approach could guide personalized exercise prescriptions to optimize cardiovascular health and functional ability in hypertension.

How similar studies have gone: Previous research supports resistance training for blood pressure control and fitness, but direct comparison of unilateral versus bilateral approaches in hypertension is limited yet plausible.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 40 to 75 years.
* Physician-confirmed diagnosis of hypertension.
* Medically stable and able to safely participate in a supervised resistance training program.
* Able to understand the study procedures and provide written informed consent.

Exclusion Criteria:

* Presence of cardiovascular diseases other than hypertension.
* Neurological disorders.
* Psychiatric disorders.
* Orthopedic conditions limiting participation in resistance exercise.
* Any other systemic disease that may interfere with study participation.
* Cognitive impairment or psychological conditions preventing completion of the assessments.
* History of recent surgery or medical conditions contraindicating exercise.
* Inability or unwillingness to comply with the study protocol.

Where it's running

  • Munzur University Faculty of Health Sciences
    Tunceli, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.